This content was created by Everyday Health Media on behalf of an advertiser.
More Information.
Content on this page was created by the Everyday Health Media team and is funded by an advertiser. The content conforms to Everyday Health Media’s editorial standards for accuracy, objectivity, and balance. The advertiser may select the specialty area but does not edit or approve the content.
Transthyretin Amyloidosis (ATTR-CM) in Focus
Rare Forms of Cardiac Amyloidosis: About the Diagnostic Clues
Despite being less common than other forms of cardiac amyloidosis, Apo AI amyloidosis and Apo AIV amyloidosis often deserve diagnostic consideration, according to these investigators.
Are Implantable Pacing Devices Necessary for Prophylaxis of ATTR-CM?
Transthyretin amyloid cardiomyopathy can lead to heart failure and conduction abnormalities. Prophylactic permanent pacing devices or implantable cardioverter-defibrillators may not be needed in these patients, but they should be closely monitored.
Obstructive CAD: Its Role and Prognostic Significance in ATTR-CM
This study revealed that obstructive epicardial coronary artery disease (oCAD) often predates the diagnosis of ATTR-CM but does not significantly impact major clinical outcomes. Its presence does not necessitate additional investigations or interventions, nor does it significantly influence mortality or hospitalization rates.
Transthyretin Amyloid Cardiomyopathy: How Does it Affect Quality of Life?
Health-related quality of life is lower for patients with transthyretin amyloid cardiomyopathy than for patients with other cardiac diseases, especially for those patients with more severe disease.